Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention

被引：0
|
作者：
Shuhei Takahashi
Kazunori Shimada
Katsumi Miyauchi
Tetsuro Miyazaki
Eiryu Sai
Manabu Ogita
Shuta Tsuboi
Hiroshi Tamura
Shinya Okazaki
Tomoyuki Shiozawa
Shohei Ouchi
Tatsuro Aikawa
Tomoyasu Kadoguchi
Hamad Al Shahi
Takuma Yoshihara
Makoto Hiki
Kikuo Isoda
Hiroyuki Daida
机构：
[1] Juntendo University Graduate School of Medicine,Department of Cardiovascular Medicine
来源：
Cardiovascular Diabetology | / 15卷
关键词：
Postprandial hyperglycemia; 1,5-Anhydroglucitol; Coronary artery disease; Cardiovascular events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] RELATIONSHIP BETWEEN BRAIN NATRIURETIC PEPTIDE LEVELS IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER PERCUTANEOUS CORONARY INTERVENTION AND CARDIOVASCULAR EVENTS
    Liao Wei
    Zhou Aiqin
    HEART, 2010, 96 : A118 - A119
  • [22] Sex and age differences of major cardiovascular events in patients after percutaneous coronary intervention
    Yang, Ya-Ling
    Chen, Su-Chan
    Wu, Cheng-Hsueh
    Huang, Shao-Sung
    Chan, Wan Leong
    Lin, Shing-Jong
    Chou, Chia-Yu
    Chen, Jaw-Wen
    Pan, Ju-Pin
    Charng, Min-Ji
    Chen, Ying-Hwa
    Wu, Tao-Cheng
    Lu, Tse-Min
    Hsu, Pai-Feng
    Huang, Po-Hsun
    Cheng, Hao-Min
    Huang, Chin-Chou
    Sung, Shih-Hsien
    Lin, Yenn-Jiang
    Leu, Hsin-Bang
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2023, 86 (12) : 1046 - 1052
  • [23] A decrease in serum 1,5-anhydroglucitol levels is associated with the presence of a first-degree family history of diabetes in a Chinese population with normal glucose tolerance
    Hu, X.
    He, X.
    Ma, X.
    Su, H.
    Ying, L.
    Peng, J.
    Wang, Y.
    Bao, Y.
    Zhou, J.
    Jia, W.
    DIABETIC MEDICINE, 2018, 35 (01) : 131 - 136
  • [24] Intervention study of continuous nursing on recurrent adverse cardiovascular events in patients after percutaneous coronary intervention
    Liu, Qiaoling
    Liu, Zhiping
    Wei, Tanwei
    MINERVA SURGERY, 2023, 78 (03): : 337 - 339
  • [25] Growth Differentiation Factor-15 is a New Predictor of Cardiovascular Events in Atrial Fibrillation Patients After Elective Percutaneous Coronary Intervention
    Krivosheeva, Elena
    Kropacheva, Ekaterina
    Titaeva, Elena
    Dobrovolsky, Anatoly
    Samko, Anatoly
    Panchenko, Elizaveta
    CIRCULATION, 2020, 142
  • [26] Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention
    Sud, Maneesh
    Han, Lu
    Koh, Maria
    Abdel-Qadir, Husam
    Austin, Peter C.
    Farkouh, Michael E.
    Godoy, Lucas C.
    Lawler, Patrick R.
    Udell, Jacob A.
    Wijeysundera, Harindra C.
    Ko, Dennis T.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (12) : 1440 - 1450
  • [27] Serum lipoprotein(a) predicts 1-year major cardiovascular events in patients after percutaneous coronary intervention
    Zhang, Jie
    Liu, Mengyu
    Ferdous, Misbahul
    Zhao, Peng
    Li, Xiujun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (01): : 165 - 174
  • [28] Relationship between serum uric acid levels and the incidence of cardiovascular events after percutaneous coronary intervention
    Matsumoto, Ichiro
    Moriya, Seiji
    Kurozumi, Mizuki
    Namba, Tsunetatsu
    Takagi, Yuichiro
    JOURNAL OF CARDIOLOGY, 2021, 78 (06) : 550 - 557
  • [29] Percutaneous coronary intervention in cancer patients with chronic coronary artery disease is associated with lower major cardiovascular events
    Pileggi, Brunna
    Franci, Andre
    Saretta, Roberta
    Baracioli, Luciano
    Drager, Luciano
    Filho, Roberto Kalil
    CIRCULATION, 2024, 150
  • [30] Untreated Sleep Apnea Syndrome is Associated With Higher Incidence of Cardiovascular Events After Percutaneous Coronary Intervention
    Fujiyoshi, Kazuhiro
    Minami, Yoshiyasu
    Ishida, Kohki
    Ishida, Miwa
    Wakabayashi, Ken-ichiro
    Ako, Junya
    Inomata, Takayuki
    CIRCULATION, 2020, 142
12345